Paper2254635
Criteria of drug-induced liver disorders. Report of an international consensus meeting.
Bénichou C. J Hepatol, 1990. Cited by 908 papers, by iCite.
Cite this record
ConductScience Library. Criteria of drug-induced liver disorders. Report of an international consensus meeting. Papers, record 2254635. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2254635
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Chemical and Drug Induced Liver Injury | Major topic |
| France | |
| Humans | |
| International Cooperation | |
| Pilot Projects |
Source PubMed
Trials2
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT00828503 | Certican® (Everolimus) Against Cytomegalovirus Disease in Renal Transplant Patients | Background | ClinicalTrials.gov | |
| NCT06618573 | Safety of Administering Isoniazid to SLE Patients to Prevent TB | Background | ClinicalTrials.gov |
Cited by332
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 908 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42757445 | Multicenter Evaluation of Large Language Models Versus Hepatologists for Prognostic Prediction in Drug-Induced Liver Injury. | Liver Int | 2026 | https://conductscience.org/library/papers/42757445 | PubMed |
| 42653701 | Hepatotoxicity Profile of Bortezomib-Containing Regimens for First-Line Multiple Myeloma Treatment. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42653701 | PubMed |
| 42639177 | Precision treatment and frontier advances of glycyrrhizin preparations in drug-induced liver injury (DILI). | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42639177 | PubMed |
| 42427211 | Ceftriaxone-induced liver injury: Incidence, phenotypic characterization and predictive factors. | Br J Clin Pharmacol | 2026 | https://conductscience.org/library/papers/42427211 | PubMed |
| 42388594 | Early Initiation of Adjuvant Nivolumab After Esophagectomy Is Associated With Immune-related Liver Injury. | Cancer Diagn Progn | 2026 | https://conductscience.org/library/papers/42388594 | PubMed |
| 42368566 | Systematic review on genetic polymorphisms associated with idiosyncratic drug-induced liver injury (iDILI): iDILInet as an interactive visualization tool. | Acta Pharm Sin B | 2026 | https://conductscience.org/library/papers/42368566 | PubMed |
| 42367407 | Ashwagandha (Withania somnifera)-Associated Liver Injury: A Scoping Review of Clinical Characteristics and Safety Considerations. | Cureus | 2026 | https://conductscience.org/library/papers/42367407 | PubMed |
| 42331581 | Development of phenotype algorithms for the detection of adverse events in electronic health record data: a multicentre study. | BMJ Open | 2026 | https://conductscience.org/library/papers/42331581 | PubMed |
| 42003579 | Fluconazole-induced liver injury in patients with pulmonary cryptococcosis: a comprehensive study integrating clinical cohort analysis, network toxicology, molecular docking, and transcriptomics. | Antimicrob Agents Chemother | 2026 | https://conductscience.org/library/papers/42003579 | PubMed |
| 41982764 | Hepatoprotective Effects of Fused Pyridine Derivatives: Regulation of the TGF-β/Smad, miR-21/Smad7, and PPARγ Pathways in Carbon Tetrachloride-Induced Liver Fibrosis. | Drug Des Devel Ther | 2026 | https://conductscience.org/library/papers/41982764 | PubMed |
| 41949784 | Characteristic histopathology of phenprocoumon-induced liver injury: correlation with clinical presentation and outcome. | Virchows Arch | 2026 | https://conductscience.org/library/papers/41949784 | PubMed |
| 41910704 | A Scoping Review of Case-Level Causality Assessment Tools Developed Between 2008 and 2023; Strengths, Weaknesses and Potential Future Improvements. | Drug Saf | 2026 | https://conductscience.org/library/papers/41910704 | PubMed |
| 41828002 | Beyond the Pump: The Evolving Molecular Landscape of Intrahepatic Cholestasis. | Diagnostics (Basel) | 2026 | https://conductscience.org/library/papers/41828002 | PubMed |
| 41811912 | Immunophenotypic Stratification of Primary Sjögren's Syndrome Reveals Distinct Lymphocyte Profiles and Clinical Manifestations. | J Immunol Res | 2026 | https://conductscience.org/library/papers/41811912 | PubMed |
| 41693786 | The incidence of chronic drug-induced liver injury: a systematic review and meta-analysis. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/41693786 | PubMed |
| 41400033 | Soft-Drug-Inspired MnSTF Nano-Adjuvant for Safe and Synergistic cGAS-STING Activation in Tumor Immunotherapy. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/41400033 | PubMed |
| 41399345 | Identification of Genetic Risk Factors Associated With Herbal and Dietary Supplement-Induced Acute Liver Failure Using Whole Exome Sequencing Analysis. | Gastro Hep Adv | 2025 | https://conductscience.org/library/papers/41399345 | PubMed |
| 41255460 | Drug-Induced Liver Injury Associated With Turmeric and Black Pepper Based Dietary Supplements Consumption: A Case Report. | Clin Case Rep | 2025 | https://conductscience.org/library/papers/41255460 | PubMed |
| 41158894 | Probable Cinnamon-Induced Mixed Hepatocellular-Cholestatic Liver Injury in a Young Woman: A Case Report. | Cureus | 2025 | https://conductscience.org/library/papers/41158894 | PubMed |
| 41030704 | The Straw That Broke the Camel's Back: Amoxicillin-Clavulanate Unraveling Autoimmune Hepatitis in a Previously Asymptomatic Female. | Cureus | 2025 | https://conductscience.org/library/papers/41030704 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2254635
GET https://conductscience.org/api/papers/v1/2254635/cited_by?page=2